Insider · CIK 0001916145
Jonathan Siegal
Files at VCEL (Vericel Corp). First filing -, latest -.
Jonathan Siegal files SEC Form 4 as officer at VCEL (Vericel Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jonathan Siegal has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 25, 2025 | VCEL Vericel Corp | 1,137 0.00% of outstanding | $59k | Feb 25, 2025 | $407k |
| Feb 19, 2025 | VCEL Vericel Corp | 1,710 0.00% of outstanding | $97k | Feb 19, 2025 | $310k |
| Feb 5, 2025 | VCEL Vericel Corp | 1,092 0.00% of outstanding | $68k | Feb 5, 2025 | $242k |
| Jan 28, 2025 | VCEL Vericel Corp | 3,908 0.01% of outstanding | $242k | Jan 28, 2025 | none |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | VCEL Vericel Corp | MOption exercise Common Stock | +1,540 | $0.00 | $0 | 5,337 | Feb 26, 2026 |
| Feb 24, 2026 | VCEL Vericel Corp | FTax withholding Common Stock | -627 | $38.09 | $24k | 4,710 | Feb 26, 2026 |
| Feb 24, 2026 | VCEL Vericel Corp | MOption exercise Common Stock | +1,875 | $0.00 | $0 | 6,585 | Feb 26, 2026 |
| Feb 24, 2026 | VCEL Vericel Corp | FTax withholding Common Stock | -738 | $38.25 | $28k | 5,847 | Feb 26, 2026 |
| Feb 24, 2026 | VCEL Vericel Corp | MOption exercise Restricted Stock Unitderivative | +1,540 | - | - | 4,620 | Feb 26, 2026 |
| Feb 24, 2026 | VCEL Vericel Corp | MOption exercise Restricted Stock Unitderivative | +1,875 | - | - | 3,750 | Feb 26, 2026 |
| Feb 18, 2026 | VCEL Vericel Corp | MOption exercise Common Stock | +2,500 | $0.00 | $0 | 4,682 | Feb 20, 2026 |
| Feb 18, 2026 | VCEL Vericel Corp | FTax withholding Common Stock | -1,117 | $36.82 | $41k | 3,565 | Feb 20, 2026 |
| Feb 18, 2026 | VCEL Vericel Corp | MOption exercise Common Stock | +420 | $0.00 | $0 | 3,985 | Feb 20, 2026 |
| Feb 18, 2026 | VCEL Vericel Corp | FTax withholding Common Stock | -188 | $37.41 | $7,033 | 3,797 | Feb 20, 2026 |
| Feb 18, 2026 | VCEL Vericel Corp | MOption exercise Restricted Stock Unitderivative | +2,500 | - | - | 2,500 | Feb 20, 2026 |
| Feb 18, 2026 | VCEL Vericel Corp | MOption exercise Restricted Stock Unitderivative | +420 | - | - | 0 | Feb 20, 2026 |
| Feb 19, 2026 | VCEL Vericel Corp | AGrant or award Stock Option (Right to Buy)derivative | +6,600 | $0.00 | $0 | 6,600 | Feb 20, 2026 |
| Feb 19, 2026 | VCEL Vericel Corp | AGrant or award Restricted Stock Unitderivative | +6,160 | $0.00 | $0 | 6,160 | Feb 20, 2026 |
| Sep 30, 2025 | VCEL Vericel Corp | MOption exercise Common Stock | +938 | $0.00 | $0 | 2,440 | Oct 2, 2025 |
| Sep 30, 2025 | VCEL Vericel Corp | FTax withholding Common Stock | -370 | $31.47 | $12k | 2,070 | Oct 2, 2025 |
| Sep 30, 2025 | VCEL Vericel Corp | MOption exercise Restricted Stock Unitderivative | +938 | - | - | 0 | Oct 2, 2025 |
Questions about Jonathan Siegal
Answered from the filings on this page, as of the latest one.
Is Jonathan Siegal buying or selling?
Jonathan Siegal has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jonathan Siegal's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan Siegal has 0.
Where does Jonathan Siegal file Form 4?
Jonathan Siegal has filed Form 4 at VCEL (Vericel Corp) as Principal Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.